134 related articles for article (PubMed ID: 35038451)
1. Resveratrol loaded in cationic glucosylated liposomes to treat Staphylococcus epidermidis infections.
Pagano L; Gkartziou F; Aiello S; Simonis B; Ceccacci F; Sennato S; Ciogli A; Mourtas S; Spiliopoulou I; Antimisiaris SG; Bombelli C; Mancini G
Chem Phys Lipids; 2022 Mar; 243():105174. PubMed ID: 35038451
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and Resveratrol-Loaded Galactosylated Liposomes: Anti-Adherence and Cell Wall Damage Effects on
Prevete G; Simonis B; Mazzonna M; Mariani F; Donati E; Sennato S; Ceccacci F; Bombelli C
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136664
[TBL] [Abstract][Full Text] [Related]
3. Glucosylated liposomes as drug delivery systems of usnic acid to address bacterial infections.
Francolini I; Giansanti L; Piozzi A; Altieri B; Mauceri A; Mancini G
Colloids Surf B Biointerfaces; 2019 Sep; 181():632-638. PubMed ID: 31207445
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
Alipour M; Halwani M; Omri A; Suntres ZE
Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
[TBL] [Abstract][Full Text] [Related]
5. The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides.
Jones MN; Song YH; Kaszuba M; Reboiras MD
J Drug Target; 1997; 5(1):25-34. PubMed ID: 9524311
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis.
Sanderson NM; Jones MN
J Drug Target; 1996; 4(3):181-9. PubMed ID: 8959490
[TBL] [Abstract][Full Text] [Related]
7. Cationic liposomes as adjuvants for influenza hemagglutinin: more than charge alone.
Barnier Quer C; Elsharkawy A; Romeijn S; Kros A; Jiskoot W
Eur J Pharm Biopharm; 2012 Jun; 81(2):294-302. PubMed ID: 22487055
[TBL] [Abstract][Full Text] [Related]
8. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
9. Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines.
Manosroi A; Thathang K; Manosroi J; Werner RG; Schubert R; Peschka-Süss R
J Liposome Res; 2009; 19(2):131-40. PubMed ID: 19515000
[TBL] [Abstract][Full Text] [Related]
10. Rhamnolipid-Based Liposomes as Promising Nano-Carriers for Enhancing the Antibacterial Activity of Peptides Derived from Bacterial Toxin-Antitoxin Systems.
Sanches BCP; Rocha CA; Martin Bedoya JG; da Silva VL; da Silva PB; Fusco-Almeida AM; Chorilli M; Contiero J; Crusca E; Marchetto R
Int J Nanomedicine; 2021; 16():925-939. PubMed ID: 33603360
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes.
Samadikhah HR; Majidi A; Nikkhah M; Hosseinkhani S
Int J Nanomedicine; 2011; 6():2275-83. PubMed ID: 22072865
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin-Loaded Lipidic Nanoparticles for Antimicrobial Efficacy.
Darvishi M; Farahani S; Haeri A
Curr Pharm Des; 2021; 27(1):135-140. PubMed ID: 32611289
[TBL] [Abstract][Full Text] [Related]
13. Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol.
Bonechi C; Martini S; Ciani L; Lamponi S; Rebmann H; Rossi C; Ristori S
PLoS One; 2012; 7(8):e41438. PubMed ID: 22936976
[TBL] [Abstract][Full Text] [Related]
14. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm.
Moghadas-Sharif N; Fazly Bazzaz BS; Khameneh B; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2015 Mar; 41(3):445-50. PubMed ID: 24405445
[TBL] [Abstract][Full Text] [Related]
15. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
[TBL] [Abstract][Full Text] [Related]
16. Development of highly stable and low toxic cationic liposomes for gene therapy.
Manosroi A; Thathang K; Werner RG; Schubert R; Peschka-Süss R; Manosroi J
Arzneimittelforschung; 2008; 58(10):485-92. PubMed ID: 19025056
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.
Barnier-Quer C; Elsharkawy A; Romeijn S; Kros A; Jiskoot W
Pharmaceutics; 2013 Jul; 5(3):392-410. PubMed ID: 24300513
[TBL] [Abstract][Full Text] [Related]
18. Chemical stability and cytotoxicity of human insulin loaded in cationic DPPC/CTA/DDAB liposomes.
Manosroi A; Khositsuntiwong N; Komno C; Manosroi W; Werner RG; Manosoi J
J Biomed Nanotechnol; 2011 Apr; 7(2):308-16. PubMed ID: 21702369
[TBL] [Abstract][Full Text] [Related]
19. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.
Zhao DD; Watarai S; Lee JT; Kouchi S; Ohmori H; Yasuda T
Acta Med Okayama; 1997 Jun; 51(3):149-54. PubMed ID: 9227794
[TBL] [Abstract][Full Text] [Related]
20. The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature.
Sanderson NM; Guo B; Jacob AE; Handley PS; Cunniffe JG; Jones MN
Biochim Biophys Acta; 1996 Sep; 1283(2):207-14. PubMed ID: 8809101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
